
Merrimack Pharmaceuticals, Inc.
USD15.14
+0.01 (+0.10%)
CEO
Gary L. Crocker
IPO Date
2012-03-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$15.15
Prev. Close
$15.13
Day Low
$15.14
Day High
$15.16
52W Low
$11.53
52W High
$15.89
Market Cap
$0.22B
Volume
0.92M
| JP Morgan |
| Neutral |
| Underweight |
| downgrade |
| 25 Jun 2018 | Baird | Neutral | Neutral | maintain |
| 24 Jun 2018 | JP Morgan | Neutral | Underweight | downgrade |
| 7 Oct 2016 | JP Morgan | Overweight | Neutral | downgrade |
| 6 Oct 2016 | JP Morgan | Overweight | Neutral | downgrade |
| 19 Aug 2016 | BTIG Research | Neutral | Neutral | maintain |
| 5 Aug 2016 | JP Morgan | Overweight | Overweight | maintain |